Literature DB >> 10887103

Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators.

J M Soucie1, R Nuss, B Evatt, A Abdelhak, L Cowan, H Hill, M Kolakoski, N Wilber.   

Abstract

Although persons with hemophilia are known to be at increased risk of death, no studies have examined the source of medical care and other personal characteristics for associations with mortality. To determine death rates and to identify causes of death and predictors of mortality, we studied a cohort comprised of all hemophilic males identified by a six-state surveillance system. Data were obtained by medical record review of contacts with physicians, hemophilia treatment centers (HTCs), and other sources of care during 1993-1995 and from death certificates. Factors examined included age, race, state of residence, health insurance type, medical care source, hemophilia type/severity, presence of inhibitor, liver disease, HIV infection, and AIDS. A total of 2950 subjects were followed for an average of 2.6 years. Their median age was 22 years; 73% were white, 79% had hemophilia A, 42% had severe disease, and 67% had visited an HTC. During 7575 person years (PYs) of observation, 236 persons died-an age-adjusted mortality rate of 40.4 deaths/1000 PYs; 65% of deaths were HIV related. In addition to age, factors independently associated with increased risk of death (relative risk, P value) were the following: AIDS (33.5, <.001); HIV infection (4.7, <.001); liver disease (2.4, <.001); and Medicare/Medicaid insurance (1.4,. 01). Those persons who had received care in an HTC had a significantly decreased risk of death (0.6,.002). Although HIV infection and the presence of severe liver disease remain strong predictors of mortality, survival is significantly greater among hemophilics who receive medical care in HTCs. (Blood. 2000;96:437-442)

Entities:  

Mesh:

Year:  2000        PMID: 10887103

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  65 in total

Review 1.  Adeno-associated virus-mediated gene transfer for hemophilia B.

Authors:  Katherine A High
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

Review 2.  Health services research for children with disabilities.

Authors:  James M Perrin
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

3.  Geographic location of commercial plasma donation clinics in the United States, 1980-1995.

Authors:  Robert C James; Cameron A Mustard
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

4.  Public health surveillance and data collection: general principles and impact on hemophilia care.

Authors:  J Michael Soucie
Journal:  Hematology       Date:  2012-04       Impact factor: 2.269

5.  The U.S. Thrombosis and Hemostasis Centers pilot sites program.

Authors:  N F Dowling; M G Beckman; M Manco-Johnson; K Hassell; C S Philipp; L A Michaels; S Moll; J A Heit; J Penner; R Kulkarni; S Pipe; P Bockenstedt; J Andersen; S Crudder; A H James; S Zimmerman; T L Ortel
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

Review 6.  How I treat venous thrombosis in children.

Authors:  Marilyn J Manco-Johnson
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

7.  Knowledge, attitudes, and behaviors of youths in the US hemophilia population: results of a national survey.

Authors:  Ann-Marie Nazzaro; Sally Owens; W Keith Hoots; Kelly L Larson
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

8.  Acute kidney injury in a diabetic haemophiliac: one step at a time.

Authors:  Mohammed Mahdi Althaf; Maged Hassan Hussein; Mohamed Said Abdelsalam; Sadiq Mohammed Amer
Journal:  BMJ Case Rep       Date:  2014-05-08

9.  Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice.

Authors:  M Neale Weitzmann; Susanne Roser-Page; Tatyana Vikulina; Daiana Weiss; Li Hao; W Hunter Baldwin; Kanglun Yu; Natalia Del Mazo Arbona; Meghan E McGee-Lawrence; Shannon L Meeks; Christine L Kempton
Journal:  Blood Adv       Date:  2019-02-12

Review 10.  Adeno-associated viral vectors for the treatment of hemophilia.

Authors:  Katherine A High; Xavier M Anguela
Journal:  Hum Mol Genet       Date:  2015-11-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.